Chemical Structure (Erythromycin 01)
Erythromycin Tablet, Film Coated
Product Images NDC 52536-103
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 52536-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wilshire Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (250 mg Tablet Bottle Label)
This is a description of a medication called Erythromycin. The medication comes in the form of film-coated tablets that contain 250mg of Erythromycin USP. The tablets are identified with the code format that was adopted in October 2000. The usual adult dose is one tablet to be taken every six hours. The medication should be kept in a USP tight container and stored below 86°F (30°C). There are 30 tablets in each bottle. This medication is manufactured by Wilshire Pharmaceuticals Inc in Atlanta, GA. The full prescribing information is available in the enclosure.*
Principal Display Panel (500 mg Tablet Bottle Label)
This is a bottle of 500mg Erythromycin tablets, USP manufactured by Wilshire Pharmaceuticals, Inc. The tablets are film-coated and each tablet contains 500mg of Erythromycin, USP. The recommended adult dose is one tablet every twelve hours. The bottle should be kept tightly closed and stored below 86°F (30°C) and should not be accepted if the seal over the bottle opening is broken or missing. Full prescribing information is included in the enclosure.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
